Biotech · Private company
AZTherapies, Inc.
Track this companyFree. Adds AZTherapies, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- ALZT-OP1aPhase 3 · Alzheimer's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- ALZT-OP1bPhase 3 · Alzheimer's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- ALZT-OP1a (cromolyn)Phase 2 · Amyotrophic Lateral SclerosisClinicalTrials.gov · fetched Nov 12, 2026
- ALZT-OP1 (cromolyn and ibuprofen) ALZT-OP1a (cromolyn) and ALZT-OP1b (ibuprofen)Phase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- A Safety and Biomarker Study of ALZT-OP1a in Subjects With Mild-Moderate ALS DiseasePHASE2 · TERMINATED · started Sep 8, 2020ClinicalTrials.gov NCT04428775 · fetched Nov 12, 2026
- Randomized I/II Phase Study of ALZT-OP1 Combination Therapy in Alzheimer's Disease and Normal Healthy VolunteersPHASE1 · COMPLETED · started Aug 28, 2020ClinicalTrials.gov NCT04570644 · fetched Nov 12, 2026
- Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's DiseasePHASE3 · COMPLETED · started Sep 15, 2015ClinicalTrials.gov NCT02547818 · fetched Nov 12, 2026